n.laurent
TL2 Moderator · Monterrey
Contributes reviews on supplier material. Based in Monterrey.
Joined 21 April 2025 · last posted 6d
66 posts, newest first. Showing up to 150.
-
A site rotation scheme that is easy enough to actually follow Replied, post #121 · Practice › Administration · 22 Jul 2026 · 3 likes Pinch or no pinch: the decision depends on needle length and on your own anatomy. A longer needle (8 mm and up) reaches subcutaneous tissue easily without a pinch. A…
-
Seven-day rolling means and why weekly readings mislead Replied, post #70 · Outcomes › Progress reports · 20 Jul 2026 · 2 likes post #69 answers the question as asked. The question underneath it is different. Seasonal patterns: some people report weight loss is slower in winter than summer. Body…
-
Revisiting: The best-written scientific paper you have read Replied, post #100 · Lounge › Off topic · 18 Jul 2026 · 2 likes Community norms: if you want to discuss how the community should work (not moderation decisions, which go in Meta) the Lounge is a place for that casual discussion.
-
Named, unnamed and unspecified impurities as regulatory categories — the long version Replied, post #80 · Analytics › Impurities & related substances · 15 Jul 2026 · 12 likes Truncation products: fragments from incomplete synthesis or from degradation. They elute quite differently from the intact peptide because they are much smaller and…
-
Reading a rodent study on a secretagogue without over-extrapolating — the long version Replied, post #14 · Compounds › Secretagogues & GH axis · 29 Jun 2026 · 3 likes Worth separating two things that post #10 runs together. GHRH analogues versus ghrelin mimetics are often conflated but they are different mechanisms. GHRH analogues…
-
Coming back to: A structured critique template this community uses Replied, post #34 · Evidence › Study critique · 15 Jun 2026 · 0 likes Picking up post #31: that is the part I would want checked first. Multiple comparisons: if a paper reports many outcomes, the chance of a spurious association by random…
-
Semaglutide formulation: what is in the licensed product besides the peptide Replied, post #17 · Compounds › Semaglutide · 6 Jun 2026 · 0 likes post #16 is right about the mechanism and I think understates the practical bit. The opalescent appearance in semaglutide solutions is occasionally noted and the…
-
Two scans six weeks apart on different machines: a cautionary tale Replied, post #25 · Outcomes › Body composition · 24 May 2026 · 15 likes Changes during titration: measuring body composition during active titration is less useful than measuring after dose is stable. Titration causes fluid shifts that…
-
Molecular mass of semaglutide and why the figure differs between sources Replied, post #42 · Compounds › Semaglutide · 23 Apr 2026 · 4 likes The STEP programme populations were selected: enrollment criteria required baseline body mass index over 30, no recent blood pressure crisis, no recent retinopathy, no…
-
Second pass at: Metformin co-administration and additive GI effects Replied, post #81 · Practice › Interactions · 8 Apr 2026 · 13 likes This follows post #78 rather than contradicting it. Sulfonylureas and meglitinides: these agents stimulate insulin release and carry hypoglycemia risk. Combining them…
-
Pharmacy supply in the UK and the questions you will be asked Replied, post #105 · Regional › UK & Ireland · 4 Apr 2026 · 0 likes Supply and shortage resilience: both UK and Ireland sourced primarily from European suppliers until recent disruptions. Domestic availability and pricing changed.
-
Restarting after a long gap: what the labelling implies — the long version Replied, post #9 · Practice › Dosing & titration · 30 Mar 2026 · 5 likes Holding a dose indefinitely: the trials did not study indefinite holding at a non-maximum dose. The trials escalated to a target and then held that. What happens if you…
-
Measurement error in a self-reported exposure Replied, post #20 · Evidence › Study critique · 22 Feb 2026 · 0 likes This follows post #17 rather than contradicting it. What makes a methodological criticism substantive: it identifies a specific feature of the design that materially…
-
Mass error in ppm: the arithmetic and the caveat Replied, post #101 · Analytics › Mass spectrometry · 15 Feb 2026 · 10 likes Quantitation by MS: most quantitation is done by LC-UV detection at 214 nm, not by MS, because extinction coefficients are better known. MS can quantify if an internal…
-
[2026 update] Confounding by indication, explained with a concrete example Replied, post #51 · Evidence › Study critique · 13 Feb 2026 · 2 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Reconstitution volumes that produce round numbers, tabulated Replied, post #37 · Practice › Reconstitution · 1 Feb 2026 · 19 likes Picking up post #34: that is the part I would want checked first. Over-dilution: if your target dose is 0.25 mg and your syringe is a 1 mL insulin syringe, you need a…
-
Research-use-only labelling: what it means and what it does not Replied, post #91 · Sourcing › Regulatory · 22 Jan 2026 · 9 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Pregnancy and pregnancy planning: contraindication and washout Replied, post #16 · Clinical › Special populations · 16 Jan 2026 · 31 likes Picking up post #13: that is the part I would want checked first. Disordered eating history: a history of anorexia nervosa, bulimia, or other eating disorders changes…
-
Coming back to: A community side-effect dataset, with its response rate and biases Replied, post #15 · Data & Tools › Datasets · 15 Jan 2026 · 13 likes Community-collected datasets: some members have compiled datasets from their own experience and shared them. They are self-reported, unblinded, and therefore limited as…
-
A single out-of-range value on an otherwise normal panel Replied, post #5 · Clinical › Bloodwork · 13 Jan 2026 · 32 likes post #4 answers the question as asked. The question underneath it is different. Thank you for the correction. I have edited my earlier post with a note rather than…
-
Vomiting: when it is expected and when it is a reason to stop Replied, post #111 · Practice › Side effects · 30 Dec 2025 · 0 likes This follows post #108 rather than contradicting it. Timeline matters: onset, duration, pattern over days or weeks, relationship to injection and to meals all provide…
-
Absence of evidence and evidence of absence Replied, post #9 · Research Methods › Statistics · 15 Dec 2025 · 11 likes Worth separating two things that post #5 runs together. Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather…
-
Sequence verification for an obscure compound: how it is done — what changed since Replied, post #83 · Compounds › Other compounds · 25 Nov 2025 · 0 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
[2026 update] How much of the diluent volume the powder itself displaces Replied, post #61 · Practice › Reconstitution · 25 Nov 2025 · 24 likes Coming back to post #59, because the follow-up matters more than the original answer. How much of the diluent volume the powder itself displaces: for a small peptide…
-
Lyophilisation and why the cake looks the way it does Replied, post #26 · Pharmacology › Formulation chemistry · 23 Nov 2025 · 0 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Citation sweep results: how many references did not say what was claimed Replied, post #9 · Meta › Wiki maintenance · 23 Nov 2025 · 0 likes This follows post #6 rather than contradicting it. Outdated external links: if a maintained page links to external sources and those links are broken or pages have…
-
DXA precision and the least significant change for lean mass Replied, post #4 · Outcomes › Body composition · 16 Nov 2025 · 19 likes Lean mass loss during rapid weight reduction: depends on protein intake, resistance training volume, and total energy deficit. Adequate protein and maintaining training…
-
[2026 update] What steady state means for the decision to escalate Replied, post #95 · Practice › Dosing & titration · 15 Nov 2025 · 0 likes This follows post #92 rather than contradicting it. Dose equivalence between different incretin analogues is a weak concept. The molecules differ in structure,…
-
AOD-9604 and the fragment hypothesis, revisited — does this still hold? Started this topic · Compounds › Other compounds · 8 Nov 2025 · 50 likes The question in the title: AOD-9604 and the fragment hypothesis, revisited — does this still hold? I will give what I have already checked below so nobody repeats it.…
-
[2026 update] Does dual agonism explain the effect size, or is it dose? Replied, post #37 · Compounds › Tirzepatide · 6 Oct 2025 · 17 likes On post #33 — agreed on the reasoning, with one qualification. SURPASS-2 compared tirzepatide with semaglutide 1.0 mg, the licensed diabetes dose at that time. It did…
-
Cagrilintide's dosing interval and the pharmacokinetics behind it Replied, post #92 · Compounds › Cagrilintide & amylin analogues · 5 Oct 2025 · 20 likes Coming back to post #90, because the follow-up matters more than the original answer. Nausea profile of amylin analogues: the historical agent pramlintide required…
-
Choosing a concentration on purpose rather than by accident Started this topic · Practice › Reconstitution · 28 Sep 2025 · 0 likes On the subject in the title: Choosing a concentration on purpose rather than by accident Working notes rather than a conclusion. Reporting something rather than asking…
-
A 10 mg vial reconstituted three different ways, compared — the long version Replied, post #130 · Practice › Reconstitution · 22 Sep 2025 · 1 like Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Pinch or no pinch, and how needle length changes the answer Replied, post #51 · Practice › Administration · 7 Sep 2025 · 0 likes post #50 answers the question as asked. The question underneath it is different. Angle of injection: 90 degrees into pinched tissue ensures subcutaneous placement. It…
-
Washout: how long is long enough, and for what purpose Replied, post #62 · Pharmacology › Pharmacokinetics · 2 Sep 2025 · 31 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Older adults, sarcopenia risk, and the trade-off nobody quantifies — the long version Replied, post #15 · Clinical › Special populations · 29 Aug 2025 · 33 likes Picking up post #12: that is the part I would want checked first. For anyone arriving from a search: the marked solution above is the direct answer, and the replies…
-
Why "any advice?" is the least effective ending for a post — the long version Replied, post #45 · Start Here › How to Ask · 28 Aug 2025 · 31 likes This follows post #42 rather than contradicting it. Disagreement-style questions: "I read this and it contradicts what I heard here, which is right?" is answerable. "Is…
-
Follow-up: Journal club: orforglipron phase 2 and the non-peptide question Replied, post #47 · Evidence › Journal club · 25 Aug 2025 · 23 likes This follows post #44 rather than contradicting it. TRIUMPH (ongoing): Retatrutide phase 3. No results yet. Nothing should be attributed to it because it has not…
-
Coming back to: Resolution and tailing factor: real acceptance criteria Replied, post #33 · Analytics › HPLC & UHPLC · 11 Aug 2025 · 0 likes Area percent is not mass percent. It is a proportion of absorbance, weighted by each species' extinction coefficient. For closely related impurities the approximation…
-
Fatigue in the first month: how much is the drug and how much is intake — what changed… Replied, post #9 · Practice › Side effects · 29 Jul 2025 · 0 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Temperature loggers worth the money — the long version Replied, post #8 · Devices › Cold chain · 5 Jul 2025 · 5 likes On post #4 — agreed on the reasoning, with one qualification. Domestic refrigeration: most lyophilised peptides are stored at 2–8 °C (35–46 °F). That is standard…
-
A ten-fold dose error caught before injection Replied, post #57 · Devices › Syringes & needles · 30 Jun 2025 · 0 likes post #56 is right about the mechanism and I think understates the practical bit. Needle gauge: smaller numbers (30G) are finer and less painful. Larger numbers (25G)…
-
Anxiety in the first weeks: drug, situation, or both Replied, post #109 · Wellbeing › Mental health · 28 Jun 2025 · 29 likes Mood and anxiety: mood changes and anxiety are reported by some people. Baseline mental health status matters for risk. Someone with a history of depression should plan…
-
Second pass at: Journal club: STEP 4 and what a withdrawal design can prove Replied, post #33 · Evidence › Journal club · 25 Jun 2025 · 0 likes SURPASS-2 (N Engl J Med 2021): Direct comparison of tirzepatide with semaglutide 1.0 mg. The 1.0 mg dose is not the highest available, which is the central and…
-
[2026 update] An appeal that failed, and what I would do differently Replied, post #130 · Access › Insurance & coverage · 15 Jun 2025 · 32 likes Picking up post #127: that is the part I would want checked first. Formulary status: the list of covered medications and the tier (how much you pay) they are on.…
-
Follow-up: Tracking intake honestly when appetite is absent Replied, post #94 · Nutrition & Training › Protein & intake · 15 Jun 2025 · 6 likes Micronutrition alongside protein: eating protein foods that are also good sources of micronutrients (iron, B vitamins, zinc) solves two problems at once.
-
Follow-up: Why the titration planner refuses to produce a schedule below a floor Replied, post #14 · Data & Tools › Calculators · 31 May 2025 · 1 like Why calculators are not medical advice: they do arithmetic. Medical decisions are not arithmetic. A calculator that says a certain dose is "compatible with" a certain…
-
A well-designed study with a badly written abstract Replied, post #113 · Evidence › Study critique · 28 May 2025 · 0 likes post #112 is right about the mechanism and I think understates the practical bit. Confounding: in observational data, is there a third variable that explains the…
-
Why a pen's dose steps are fixed and what that costs you — one year on Replied, post #16 · Devices › Pens & autoinjectors · 28 May 2025 · 0 likes post #15 is right about the mechanism and I think understates the practical bit. Dose counters: pens show the remaining number of doses. When the counter reaches zero,…
-
[2026 update] What the GIP component of tirzepatide is thought to contribute, and how… Replied, post #60 · Compounds › Tirzepatide · 25 May 2025 · 0 likes SURMOUNT-4 used a randomised withdrawal design: everyone titrated, then those on maintenance were randomised to continue or placebo. Continuation maintained effect;…
-
Reconstituting a multi-strength kit without mixing yourself up Replied, post #74 · Practice › Reconstitution · 21 May 2025 · 26 likes Reconstituting a multi-strength kit: if a kit contains 5 mg, 10 mg, 15 mg vials and you are reconstituting all of them, writing the concentration on each vial in…
-
Cost per milligram, computed honestly across formats — the long version Replied, post #90 · Access › Pricing · 6 May 2025 · 16 likes Picking up post #87: that is the part I would want checked first. Discount programmes and coupons: manufacturers often offer coupons that reduce out-of-pocket costs if…
-
Follow-up: What other technical communities get right that we do not Replied, post #47 · Lounge › Off topic · 23 Mar 2025 · 0 likes Humour: light, relevant humour is welcome. Cruel humour targeting individuals or groups is not.
-
When to suspect the method rather than the sample Replied, post #99 · Analytics › Method validation · 18 Mar 2025 · 8 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Journal club: STEP 4 and what a withdrawal design can prove — one year on Replied, post #44 · Evidence › Journal club · 11 Mar 2025 · 9 likes post #43 answers the question as asked. The question underneath it is different. For anyone arriving from a search: the marked solution above is the direct answer, and…
-
[2026 update] Dose numbers across compounds are not on the same scale Replied, post #5 · Practice › Dosing & titration · 24 Feb 2025 · 0 likes How the published trials escalated: they used specific step sizes and intervals. The STEP programme used a particular cadence; the SURPASS and SURMOUNT programmes used…
-
Research-use-only status: what it means legally and practically — a second dataset Replied, post #55 · Compounds › Other compounds · 3 Jan 2025 · 0 likes Picking up post #52: that is the part I would want checked first. Reading a supplier's product description as a marketing document: that is exactly what it is. The…
-
Fixed versus detachable needles: the trade-offs Replied, post #81 · Devices › Syringes & needles · 30 Dec 2024 · 6 likes Aspirating before injection: for subcutaneous injection, aspirating (pulling back on the plunger to check for blood) is not necessary and is sometimes discouraged…
-
[2026 update] How to read a forest plot, properly, from scratch Replied, post #18 · Evidence › Trials · 5 Dec 2024 · 2 likes Intent-to-treat versus per-protocol: ITT includes everyone assigned regardless of whether they took the drug. Per-protocol includes only those who completed it as…
-
Time to steady state after a dose increase Replied, post #65 · Pharmacology › Pharmacokinetics · 4 Nov 2024 · 2 likes post #64 answers the question as asked. The question underneath it is different. Albumin binding: semaglutide binds albumin through a fatty side chain, which sequesters…
-
How to ask for a dose change without antagonising anyone — what changed since Replied, post #19 · Clinical › Prescriber conversations · 31 Oct 2024 · 26 likes Discussing off-label dosing: if you want to dose differently than the label specifies (slower titration, higher final dose), discussing that explicitly and…
-
Levothyroxine timing: a real interaction with a simple fix Replied, post #5 · Practice › Interactions · 28 Oct 2024 · 13 likes SGLT2 inhibitors: frequently co-administered and relevant to renal and cardiovascular discussion, not to interactions. There is no pharmacokinetic interaction of concern.
-
Hypertension improvement and when medication needs revisiting — a second dataset Replied, post #116 · Clinical › Comorbidities · 27 Oct 2024 · 7 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Second pass at: Hoarding and why it makes a shortage worse Replied, post #103 · Access › Shortages · 13 Oct 2024 · 32 likes Resuming after a gap: after a gap of days or a few weeks, most people resume at the dose they were on when they stopped. Gaps of months might require retitration…
-
Circumference measurements as a poor man's composition estimate Replied, post #58 · Outcomes › Body composition · 11 Aug 2024 · 0 likes Resting metabolic rate: body composition affects metabolic rate. As fat mass decreases and lean mass is maintained, metabolic rate is usually maintained better than…
-
Second pass at: Retatrutide dose escalation in the published trials Replied, post #78 · Compounds › Retatrutide · 21 Jul 2024 · 0 likes TRIUMPH is phase 3 and it is ongoing. No phase 3 results exist. Nothing should be attributed to TRIUMPH because the trial has not finished. When it does, this page will…